[Hematopoietic stem cell transplantation after nonmyeloablative conditioning].
In these last years it has become evident that nonmyeloablative stem cell transplantation (NST) is a feasible procedure at least in the first 100 days. Generally NST has less severe adverse effects than conventional allografting. Unfortunately, short observation period cannot permit us to give a definitive reply to the question if this procedure will substitute the conventional myeloablative transplantation. NST is a promising new option for the treatment of hematologic and non-hematologic neoplasia, which role will be better defined in the near future.
Carella
A M
AM
Divisione di Ematologia, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo.
D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D019653:Myeloablative Agonists; D009369:Neoplasms / Q000628:therapy*; D019172:Transplantation Conditioning / Q000379:methods
D019653:Myeloablative Agonists